[(3S,10R,13S,17R)-17-[1-(benzylamino)-1-oxopropan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate

C31H43NO3 — CID 71590546

IUPAC[(3S,10R,13S,17R)-17-[1-(benzylamino)-1-oxopropan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
SMILESCC(=O)O[C@H]1CC[C@@]2(C)C(=CCC3C2CC[C@@]2(C)C3CC[C@@H]2C(C)C(=O)NCc2ccccc2)C1
InChIInChI=1S/C31H43NO3/c1-20(29(34)32-19-22-8-6-5-7-9-22)26-12-13-27-25-11-10-23-18-24(35-21(2)33)14-16-30(23,3)28(25)15-17-31(26,27)4/h5-10,20,24-28H,11-19H2,1-4H3,(H,32,34)/t20?,24-,25?,26+,27?,28?,30-,31+/m0/s1
InChIKeyFTBHKNVKRQUGLJ-MYESGHAASA-N
MW477.69 g/mol
LogP6.45
Rot. Bonds5

About [(3S,10R,13S,17R)-17-[1-(benzylamino)-1-oxopropan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate

[(3S,10R,13S,17R)-17-[1-(benzylamino)-1-oxopropan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate (PubChem CID 71590546) has the molecular formula C31H43NO3 and a molecular weight of 477.69 g/mol. Its IUPAC name is [(3S,10R,13S,17R)-17-[1-(benzylamino)-1-oxopropan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate.

Molecular Properties

Compound Name[(3S,10R,13S,17R)-17-[1-(benzylamino)-1-oxopropan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
PubChem CID71590546
Molecular FormulaC31H43NO3
Molecular Weight477.69 g/mol
Exact Mass477.32
IUPAC Name[(3S,10R,13S,17R)-17-[1-(benzylamino)-1-oxopropan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
SMILESCC(=O)O[C@H]1CC[C@@]2(C)C(=CCC3C2CC[C@@]2(C)C3CC[C@@H]2C(C)C(=O)NCc2ccccc2)C1
InChIInChI=1S/C31H43NO3/c1-20(29(34)32-19-22-8-6-5-7-9-22)26-12-13-27-25-11-10-23-18-24(35-21(2)33)14-16-30(23,3)28(25)15-17-31(26,27)4/h5-10,20,24-28H,11-19H2,1-4H3,(H,32,34)/t20?,24-,25?,26+,27?,28?,30-,31+/m0/s1
InChIKeyFTBHKNVKRQUGLJ-MYESGHAASA-N
XLogP6.45
TPSA55.40 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds5
Heavy Atoms35
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500477.69
LogP ≤ 56.45
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(3S,10R,13S,17R)-17-[1-(benzylamino)-1-oxopropan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(3S,10R,13S,17R)-17-[1-(benzylamino)-1-oxopropan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate?
The IUPAC name of [(3S,10R,13S,17R)-17-[1-(benzylamino)-1-oxopropan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate (CID 71590546) is [(3S,10R,13S,17R)-17-[1-(benzylamino)-1-oxopropan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate.
What is the SMILES notation for [(3S,10R,13S,17R)-17-[1-(benzylamino)-1-oxopropan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate?
The canonical SMILES for [(3S,10R,13S,17R)-17-[1-(benzylamino)-1-oxopropan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate is CC(=O)O[C@H]1CC[C@@]2(C)C(=CCC3C2CC[C@@]2(C)C3CC[C@@H]2C(C)C(=O)NCc2ccccc2)C1.
What is the InChIKey of [(3S,10R,13S,17R)-17-[1-(benzylamino)-1-oxopropan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate?
The InChIKey is FTBHKNVKRQUGLJ-MYESGHAASA-N. The full InChI is InChI=1S/C31H43NO3/c1-20(29(34)32-19-22-8-6-5-7-9-22)26-12-13-27-25-11-10-23-18-24(35-21(2)33)14-16-30(23,3)28(25)15-17-31(26,27)4/h5-10,20,24-28H,11-19H2,1-4H3,(H,32,34)/t20?,24-,25?,26+,27?,28?,30-,31+/m0/s1.
What are the key properties of [(3S,10R,13S,17R)-17-[1-(benzylamino)-1-oxopropan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate?
[(3S,10R,13S,17R)-17-[1-(benzylamino)-1-oxopropan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate has a molecular weight of 477.69 g/mol, XLogP of 6.45, 5 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for [(3S,10R,13S,17R)-17-[1-(benzylamino)-1-oxopropan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate is sourced from PubChem (CID 71590546), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).